Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1 7Phase 1/2 5Phase NA 4Phase EARLY_PHASE1 4Phase 4 4Phase 3 4

Status

Completed 22Recruiting 13Terminated 8Unknown 5Not yet recruiting 4Active not recruiting 3Withdrawn 1Suspended 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 59Multiple Myeloma 53Colorectal Neoplasms 48Lymphoma 46Recurrence 45Carcinoma, Hepatocellular 45Stomach Neoplasms 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Prostatic Neoplasms 34Melanoma 34Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Interventions

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3camrelizumab 1apatinib 1Gemcitabine 1Dexamethasone 1Dasatinib 1Cisplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Lymphoma, T-Cell, Peripheral × Clear all
NCT06173999 2024-05-14

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Jiangsu HengRui Medicine Co., Ltd.

Phase 1/2 Unknown
100 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT06083701 2023-10-16

Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study

Peking Union Medical College Hospital

Phase 1/2 Unknown
32 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05559008 2022-11-09

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

Ruijin Hospital

Phase 1/2 Unknown
116 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05527275 2022-09-02

A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

Sun Yat-sen University

Phase 1/2 Unknown
78 enrolled
Lymphoid

Recurrence, Lymphoma, T-Cell, Peripheral

NCT05441761 2022-07-01

Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL

Peking Union Medical College Hospital

Phase 1/2 Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡